Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, discusses new therapies for Alzheimer’s Disease. The FDA has currently approved 5 symptomatic therapies…
Ian A Cook, MD, Director of Unipolar Depression Research, UCLA David Geffen School of Medicine, discusses the use of measurement – based care for depressed patients, which can…
Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, discusses biomarkers in Alzheimer’s Disease, which are currently used in clinical trials as inclusion…
Donnica Moore, MD, President, Sapphire Women’s Health Group, discusses Chronic Fatigue Syndrome and what it is not. She describes in detail how to differentiate CFS from depression, fatigue…
Donnica Moore, MD, President, Sapphire Women’s Health Group, discusses Chronic Fatigue Syndrome or CFS, its definition and symptoms. CFS is a chronic, debilitating neuroimmune disease that not only…
NEW YORK (Reuters Health) – Consistent with their ability to block platelet aggregation, selective serotonin reuptake inhibitors (SSRIs) appear to increase the risk of serious upper gastrointestinal (GI)…
NEW YORK (Reuters Health) – Treatment of depression in low-income minorities with poorly controlled diabetes improved HbA1c and systolic blood pressure, investigators report in the December issue of…
NEW YORK (Reuters Health) – In children with attention deficit hyperactivity disorder (ADHD), adding divalproex to stimulant therapy can improve refractory aggression, a small study suggests. “Stimulant medications…
Ian A Cook, MD, Director, Unipolar Depression Research, UCLA David Geffen School of Medicine, discusses a new depression treatment using gentle brain stimulation called TMS, or transcranial magnetic…
Ian A Cook, MD, Director, Unipolar Depression Research, UCLA David Geffen School of Medicine, discusses a new depression treatment using gentle brain stimulation and TMS, or transcranial magnetic…